RAVULIZUMAB

Clinical Indication

Treating atypical haemolytic uraemic syndrome (aHUS)

Comments

Only for use in specialist centres or in secondary care under an agreed tertiary centre as per NICE TA710.

Date of classification

September 2021

Review date

September 2021

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LMSG website list.